# Skyline Vet Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/skyline-vet-pharma

- Industry: Pharmaceuticals
- Headquarters: US
- Total disclosed funding: $5M
- Latest round: Series A (Apr 13, 2017)
- Investors on record: 10

## About

Based in Connecticut, US, and founded in 2015, Skyline Vet Pharma, Inc., also known as SVP, operates as a pharmaceutical company. The company was founded by its CEO, Serge Martinod, and George Murphy. In April 2017, Skyline Vet Pharma, Inc. raised USD 5 million in Series A financing from AgTech Accelerator, Alexandria Venture Investments, ARCH Venture Partners, and Elanco Animal Health, Inc.

Skyline Vet Pharma conducts research and creates pharmaceuticals for the animal health market. SVP uses novel delivery technologies to reformulate drugs that are used in the animal health industry. The company’s platform uses veterinarian-written prescriptions used by customers to purchase medications.

## Funding rounds

- Series A, Apr 13, 2017, $5M — ARCH Venture Partners, Flagship Pioneering, Pappas Capital, Alexandria Venture Investments, Hatteras Venture Partners, Bill & Melinda Gates Foundation, Mountain Group Partners, Syngenta Ventures, AgTech Accelerator, Elanco Animal Health, Inc.

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A
- Bill & Melinda Gates Foundation — Series A
- Mountain Group Partners (https://capitalatlas.ai/funds/mountain-group-partners) — Series A
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series A
- AgTech Accelerator — Series A
- Elanco Animal Health, Inc. — Series A